Selected research
Market Analysis & Forecast
Global Efavirenz Tablets Market Analysis and Forecast 2026-2032
Market perspective
The global Efavirenz Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Efavirenz Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Efavirenz Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Efavirenz Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Efavirenz Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Efavirenz Tablets include Aurobindo Pharma, Cipla, Hetero, Strides Pharma, Anhui Biochem Bio-Pharmaceutical, Huahai Pharmaceutical and DESANO, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Efavirenz Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Efavirenz Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Efavirenz Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Efavirenz Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Efavirenz Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Efavirenz Tablets sales, projected growth trends, production technology, application and end-user industry.
Efavirenz Tablets Segment by Company
Aurobindo Pharma
Cipla
Hetero
Strides Pharma
Anhui Biochem Bio-Pharmaceutical
Huahai Pharmaceutical
DESANO
Efavirenz Tablets Segment by Type
200mg
50mg
600mg
Efavirenz Tablets Segment by Application
Adult
Child
Efavirenz Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Efavirenz Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Efavirenz Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Efavirenz Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Efavirenz Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Efavirenz Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Efavirenz Tablets sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 200mg
- 50mg
- 600mg
Applications
- Adult
- Child
Companies covered
- Aurobindo Pharma
- Cipla
- Hetero
- Strides Pharma
- Anhui Biochem Bio-Pharmaceutical
- Huahai Pharmaceutical
- DESANO
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Efavirenz Tablets Market by Type
- 1.2.1 Global Efavirenz Tablets Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 200mg
- 1.2.3 50mg
- 1.2.4 600mg
- 1.3 Efavirenz Tablets Market by Application
- 1.3.1 Global Efavirenz Tablets Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Adult
- 1.3.3 Child
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Efavirenz Tablets Market Dynamics
- 2.1 Efavirenz Tablets Industry Trends
- 2.2 Efavirenz Tablets Industry Drivers
- 2.3 Efavirenz Tablets Industry Opportunities and Challenges
- 2.4 Efavirenz Tablets Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Efavirenz Tablets Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Efavirenz Tablets Revenue by Region
- 3.2.1 Global Efavirenz Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Efavirenz Tablets Revenue by Region (2021-2026)
- 3.2.3 Global Efavirenz Tablets Revenue by Region (2027-2032)
- 3.2.4 Global Efavirenz Tablets Revenue Market Share by Region (2021-2032)
- 3.3 Global Efavirenz Tablets Sales Estimates and Forecasts 2021-2032
- 3.4 Global Efavirenz Tablets Sales by Region
- 3.4.1 Global Efavirenz Tablets Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Efavirenz Tablets Sales by Region (2021-2026)
- 3.4.3 Global Efavirenz Tablets Sales by Region (2027-2032)
- 3.4.4 Global Efavirenz Tablets Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Efavirenz Tablets Revenue by Manufacturers
- 4.1.1 Global Efavirenz Tablets Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Efavirenz Tablets Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Efavirenz Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Efavirenz Tablets Sales by Manufacturers
- 4.2.1 Global Efavirenz Tablets Sales by Manufacturers (2021-2026)
- 4.2.2 Global Efavirenz Tablets Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Efavirenz Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Efavirenz Tablets Sales Price by Manufacturers (2021-2026)
- 4.4 Global Efavirenz Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Efavirenz Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Efavirenz Tablets Manufacturers, Product Type & Application
- 4.7 Global Efavirenz Tablets Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Efavirenz Tablets Market CR5 and HHI
- 4.8.2 2025 Efavirenz Tablets Tier 1, Tier 2, and Tier 3
5 Efavirenz Tablets Market by Type
- 5.1 Global Efavirenz Tablets Revenue by Type
- 5.1.1 Global Efavirenz Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Efavirenz Tablets Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Efavirenz Tablets Revenue Market Share by Type (2021-2032)
- 5.2 Global Efavirenz Tablets Sales by Type
- 5.2.1 Global Efavirenz Tablets Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Efavirenz Tablets Sales by Type (2021-2032) & (k units)
- 5.2.3 Global Efavirenz Tablets Sales Market Share by Type (2021-2032)
- 5.3 Global Efavirenz Tablets Price by Type
6 Efavirenz Tablets Market by Application
- 6.1 Global Efavirenz Tablets Revenue by Application
- 6.1.1 Global Efavirenz Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Efavirenz Tablets Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Efavirenz Tablets Revenue Market Share by Application (2021-2032)
- 6.2 Global Efavirenz Tablets Sales by Application
- 6.2.1 Global Efavirenz Tablets Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Efavirenz Tablets Sales by Application (2021-2032) & (k units)
- 6.2.3 Global Efavirenz Tablets Sales Market Share by Application (2021-2032)
- 6.3 Global Efavirenz Tablets Price by Application
7 Company Profiles
- 7.1 Aurobindo Pharma
- 7.1.1 Aurobindo Pharma Company Information
- 7.1.2 Aurobindo Pharma Business Overview
- 7.1.3 Aurobindo Pharma Efavirenz Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Aurobindo Pharma Efavirenz Tablets Product Portfolio
- 7.1.5 Aurobindo Pharma Recent Developments
- 7.2 Cipla
- 7.2.1 Cipla Company Information
- 7.2.2 Cipla Business Overview
- 7.2.3 Cipla Efavirenz Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Cipla Efavirenz Tablets Product Portfolio
- 7.2.5 Cipla Recent Developments
- 7.3 Hetero
- 7.3.1 Hetero Company Information
- 7.3.2 Hetero Business Overview
- 7.3.3 Hetero Efavirenz Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Hetero Efavirenz Tablets Product Portfolio
- 7.3.5 Hetero Recent Developments
- 7.4 Strides Pharma
- 7.4.1 Strides Pharma Company Information
- 7.4.2 Strides Pharma Business Overview
- 7.4.3 Strides Pharma Efavirenz Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Strides Pharma Efavirenz Tablets Product Portfolio
- 7.4.5 Strides Pharma Recent Developments
- 7.5 Anhui Biochem Bio-Pharmaceutical
- 7.5.1 Anhui Biochem Bio-Pharmaceutical Company Information
- 7.5.2 Anhui Biochem Bio-Pharmaceutical Business Overview
- 7.5.3 Anhui Biochem Bio-Pharmaceutical Efavirenz Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Anhui Biochem Bio-Pharmaceutical Efavirenz Tablets Product Portfolio
- 7.5.5 Anhui Biochem Bio-Pharmaceutical Recent Developments
- 7.6 Huahai Pharmaceutical
- 7.6.1 Huahai Pharmaceutical Company Information
- 7.6.2 Huahai Pharmaceutical Business Overview
- 7.6.3 Huahai Pharmaceutical Efavirenz Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Huahai Pharmaceutical Efavirenz Tablets Product Portfolio
- 7.6.5 Huahai Pharmaceutical Recent Developments
- 7.7 DESANO
- 7.7.1 DESANO Company Information
- 7.7.2 DESANO Business Overview
- 7.7.3 DESANO Efavirenz Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 DESANO Efavirenz Tablets Product Portfolio
- 7.7.5 DESANO Recent Developments
8 North America
- 8.1 North America Efavirenz Tablets Market Size by Type
- 8.1.1 North America Efavirenz Tablets Revenue by Type (2021-2032)
- 8.1.2 North America Efavirenz Tablets Sales by Type (2021-2032)
- 8.1.3 North America Efavirenz Tablets Price by Type (2021-2032)
- 8.2 North America Efavirenz Tablets Market Size by Application
- 8.2.1 North America Efavirenz Tablets Revenue by Application (2021-2032)
- 8.2.2 North America Efavirenz Tablets Sales by Application (2021-2032)
- 8.2.3 North America Efavirenz Tablets Price by Application (2021-2032)
- 8.3 North America Efavirenz Tablets Market Size by Country
- 8.3.1 North America Efavirenz Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Efavirenz Tablets Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Efavirenz Tablets Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Efavirenz Tablets Market Size by Type
- 9.1.1 Europe Efavirenz Tablets Revenue by Type (2021-2032)
- 9.1.2 Europe Efavirenz Tablets Sales by Type (2021-2032)
- 9.1.3 Europe Efavirenz Tablets Price by Type (2021-2032)
- 9.2 Europe Efavirenz Tablets Market Size by Application
- 9.2.1 Europe Efavirenz Tablets Revenue by Application (2021-2032)
- 9.2.2 Europe Efavirenz Tablets Sales by Application (2021-2032)
- 9.2.3 Europe Efavirenz Tablets Price by Application (2021-2032)
- 9.3 Europe Efavirenz Tablets Market Size by Country
- 9.3.1 Europe Efavirenz Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Efavirenz Tablets Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Efavirenz Tablets Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Efavirenz Tablets Market Size by Type
- 10.1.1 China Efavirenz Tablets Revenue by Type (2021-2032)
- 10.1.2 China Efavirenz Tablets Sales by Type (2021-2032)
- 10.1.3 China Efavirenz Tablets Price by Type (2021-2032)
- 10.2 China Efavirenz Tablets Market Size by Application
- 10.2.1 China Efavirenz Tablets Revenue by Application (2021-2032)
- 10.2.2 China Efavirenz Tablets Sales by Application (2021-2032)
- 10.2.3 China Efavirenz Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Efavirenz Tablets Market Size by Type
- 11.1.1 Asia Efavirenz Tablets Revenue by Type (2021-2032)
- 11.1.2 Asia Efavirenz Tablets Sales by Type (2021-2032)
- 11.1.3 Asia Efavirenz Tablets Price by Type (2021-2032)
- 11.2 Asia Efavirenz Tablets Market Size by Application
- 11.2.1 Asia Efavirenz Tablets Revenue by Application (2021-2032)
- 11.2.2 Asia Efavirenz Tablets Sales by Application (2021-2032)
- 11.2.3 Asia Efavirenz Tablets Price by Application (2021-2032)
- 11.3 Asia Efavirenz Tablets Market Size by Country
- 11.3.1 Asia Efavirenz Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Efavirenz Tablets Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Efavirenz Tablets Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Efavirenz Tablets Market Size by Type
- 12.1.1 SAMEA Efavirenz Tablets Revenue by Type (2021-2032)
- 12.1.2 SAMEA Efavirenz Tablets Sales by Type (2021-2032)
- 12.1.3 SAMEA Efavirenz Tablets Price by Type (2021-2032)
- 12.2 SAMEA Efavirenz Tablets Market Size by Application
- 12.2.1 SAMEA Efavirenz Tablets Revenue by Application (2021-2032)
- 12.2.2 SAMEA Efavirenz Tablets Sales by Application (2021-2032)
- 12.2.3 SAMEA Efavirenz Tablets Price by Application (2021-2032)
- 12.3 SAMEA Efavirenz Tablets Market Size by Country
- 12.3.1 SAMEA Efavirenz Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Efavirenz Tablets Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Efavirenz Tablets Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Efavirenz Tablets Value Chain Analysis
- 13.1.1 Efavirenz Tablets Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Efavirenz Tablets Production Mode & Process
- 13.2 Efavirenz Tablets Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Efavirenz Tablets Distributors
- 13.2.3 Efavirenz Tablets Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst